GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ImmunoPrecise Antibodies
Issuer Direct provides software and services for investor relations and regulatory compliance companies. Its stock price reflects capital markets activity and the need of public companies to effectively communicate with shareholders.
Share prices of companies in the market segment - Dna
ImmunoPrecise Antibodies is a biotechnology company providing therapeutic antibody discovery and development services to pharmaceutical companies. We've classified it as "DNA" because its work is focused on antibodies. The chart below shows the dynamics of the contract research sector.
Broad Market Index - GURU.Markets
ImmunoPrecise is a company that provides therapeutic antibody discovery and development services to pharmaceutical companies. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with ImmunoPrecise's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
IPA - Daily change in the company's share price ImmunoPrecise Antibodies
The daily price change of ImmunoPrecise Antibodies Ltd. reflects volatility in the biotech services sector. This indicator demonstrates sensitivity to pharmaceutical companies' R&D spending, serving as an indicator of the industry's health.
Daily change in the price of a set of shares in a market segment - Dna
ImmunoPrecise Antibodies is a biotech company that provides therapeutic antibody discovery and development services to other pharmaceutical companies. Its business serves as a barometer for the health of the entire industry. The chart below shows the volatility in this sector, helping to assess the dynamics of the IPA.
Daily change in the price of a broad market stock, index - GURU.Markets
ImmunoPrecise Antibodies is a biotech company providing antibody development services to other pharmaceutical companies. Its business serves as a barometer of R&D activity in the industry. Its stock price is an indicator of innovation activity, influencing the overall market environment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ImmunoPrecise Antibodies
ImmunoPrecise Antibodies' year-over-year performance tells the story of its role as a contract research organization (CRO). Its market capitalization growth over the past 12 months reflects demand from pharmaceutical companies for its antibody discovery and development services. Its valuation is a bet on the availability of its scientific expertise for the development of new drugs.
Annual dynamics of market capitalization of the market segment - Dna
ImmunoPrecise, a contract research organization (CRO), specializes in antibody development. Its performance relative to the sector will demonstrate the level of demand for its services from pharmaceutical companies, making it a barometer for R&D activity in this important field.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ImmunoPrecise Antibodies, a company providing therapeutic antibody development services, is a service player in the biotech ecosystem. Its annual market capitalization dynamics reflect the overall activity and R&D spending in the pharmaceutical industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ImmunoPrecise Antibodies
ImmunoPrecise is a contract research organization (CRO) specializing in antibody development. Its business depends on R&D spending in the biotech sector. Monthly fluctuations in its value reflect demand for its services and news of new contracts.
Monthly dynamics of market capitalization of the market segment - Dna
This chart reflects the dynamics of the pharmaceutical services sector. For ImmunoPrecise, a contract research organization (CRO), it provides context. Its growth reflects outsourcing trends in R&D and the continued demand for its antibody development services.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ImmunoPrecise Antibodies is a company that provides therapeutic antibody discovery and development services for the pharmaceutical industry. Its business model is a biotech "pick and shovel" approach. A full-market chart allows you to assess how closely ImmunoPrecise's stock, as a service provider, moves in sync with overall sentiment in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a company that provides therapeutic antibody development services to other pharmaceutical companies. Its weekly stock price is driven by demand for R&D outsourcing and partnership news.
Weekly dynamics of market capitalization of the market segment - Dna
ImmunoPrecise Antibodies is a biotech company providing antibody discovery and development services to other pharmaceutical companies. Its business is part of the research ecosystem. The chart helps us understand whether the IPA trend reflects overall activity in the R&D sector or whether its proprietary technology platforms are attracting particular interest.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ImmunoPrecise is a biotech company. Its shares move on news about clinical trials. This chart clearly demonstrates how much its performance is driven by scientific news rather than general market trends.
Market capitalization of the company, segment and market as a whole
IPA - Market capitalization of the company ImmunoPrecise Antibodies
ImmunoPrecise Antibodies' market capitalization reflects its activities as a contract research organization specializing in the discovery and development of antibodies for pharmaceutical companies. Its chart shows how investors view its role as a "science outsourcer" in the growing biopharmaceuticals industry.
IPA - Share of the company's market capitalization ImmunoPrecise Antibodies within the market segment - Dna
ImmunoPrecise Antibodies is a biotech service company that helps other companies develop therapeutic antibodies. Its market share is small, but it is a vital link in the R&D ecosystem. The chart shows its importance as an outsourcing partner for the pharmaceutical and biotech industries.
Market capitalization of the market segment - Dna
The chart below shows the market capitalization of the biotech services sector. ImmunoPrecise Antibodies is a company that helps other pharmaceutical companies discover and develop new antibodies. It is essentially a "science outsourcer." Its success in the market depends on the overall health of R&D in the industry and its ability to deliver cutting-edge technologies.
Market capitalization of all companies included in a broad market index - GURU.Markets
ImmunoPrecise is a company that provides therapeutic antibody development and discovery services to other pharmaceutical companies. Its market capitalization reflects its role in this ecosystem. The chart below shows the economic weight of the research outsourcing sector.
Book value capitalization of the company, segment and market as a whole
IPA - Book value capitalization of the company ImmunoPrecise Antibodies
ImmunoPrecise's book value reflects its diversified antibody discovery and development platform, which provides services to biotech and pharmaceutical companies. The chart tells the story of a life sciences services company building its foundation on a broad range of technologies that support the R&D of other players.
IPA - Share of the company's book capitalization ImmunoPrecise Antibodies within the market segment - Dna
ImmunoPrecise Antibodies is a contract research organization (CRO). The chart shows its share of actual R&D assets. Its business consists of laboratories and unique platforms for the discovery and development of antibodies for other pharmaceutical companies.
Market segment balance sheet capitalization - Dna
ImmunoPrecise Antibodies is a contract research organization specializing in antibody discovery and development. Their business is services and science, which require cutting-edge laboratories. The book value chart shows the value of this scientific infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
ImmunoPrecise Antibodies is a network of laboratories in North America and Europe equipped to discover and develop therapeutic antibodies. The chart shows how this international scientific infrastructure has grown.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ImmunoPrecise Antibodies
ImmunoPrecise Antibodies provides antibody development services to pharmaceutical companies. Its value lies in its scientific expertise and technology. The chart below shows how the market views its role in the drug discovery ecosystem. Growth in biotech is driving demand for its services and pushing its valuation upward.
Market to book capitalization ratio in a market segment - Dna
ImmunoPrecise Antibodies is a company that provides therapeutic antibody discovery and development services to pharmaceutical companies. Its value lies in its technology platform and expertise. The chart shows how the market values its service business model, which helps other companies develop drugs.
Market to book capitalization ratio for the market as a whole
ImmunoPrecise Antibodies provides antibody development services to pharmaceutical companies. It's a service business based on scientific expertise. This chart shows that the market values the company not on the value of its laboratories, but on its technological platform and ability to contribute to the development of successful drugs.
Debts of the company, segment and market as a whole
IPA - Company debts ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) that provides services for the discovery and development of therapeutic antibodies. This chart shows its financial model. Revenue from contracts with pharmaceutical companies funds its operations and investments in its proprietary technology platforms.
Market segment debts - Dna
ImmunoPrecise Antibodies is a contract research organization (CRO) that specializes in the discovery and development of therapeutic antibodies for other companies. It's a service business at the heart of the biotech industry. This chart shows how its financial model differs from companies developing their own drugs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a biotech company providing antibody development services. This chart shows its financial structure. For a biotech service company, maintaining a strong balance sheet is crucial to inspiring confidence among large pharmaceutical clients.
Market segment debt to market segment book capitalization - Dna
ImmunoPrecise Antibodies is a company that provides therapeutic antibody development services to the pharmaceutical industry. This chart shows the debt burden in the biotech sector. It helps understand how service companies in this industry finance their research and technology to support their clients' development.
Debt to book value of all companies in the market
ImmunoPrecise Antibodies is a company that provides therapeutic antibody development services to other pharmaceutical companies. It's a service business at the heart of biopharma. This chart of total market debt provides context for assessing its financial model. How reliant is it on debt to expand its laboratory capacity?
P/E of the company, segment and market as a whole
P/E - ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) that specializes in the discovery and development of therapeutic antibodies for other pharmaceutical and biotech companies. This chart shows how investors value R&D outsourcing.
P/E of the market segment - Dna
ImmunoPrecise Antibodies is a company providing therapeutic antibody development and discovery services to pharmaceutical and biotech companies. They partner with early-stage drug development. This chart shows the overall valuation of the DNA technologies sector, reflecting how investors value service companies supporting innovation in biopharma.
P/E of the market as a whole
ImmunoPrecise Antibodies is a company that helps other pharmaceutical companies develop therapeutic antibodies. Its business depends on the volume of R&D in the pharmaceutical industry. This general sentiment trend influences biotech funding, but for ImmunoPrecise, the long-term trend toward outsourcing research is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a company that provides therapeutic antibody discovery and development services to pharmaceutical companies. This chart illustrates future revenue expectations, which depend on outsourcing trends in R&D and the success of projects the company is working on with partners.
%20P%2FE%20ImmunoPrecise%20Antibodies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ImmunoPrecise-Antibodies&v=1772684597600 "Chart of the company's future (projected) P/E ImmunoPrecise Antibodies")
Future (projected) P/E of the market segment - Dna
ImmunoPrecise Antibodies is a company providing therapeutic antibody discovery and development services to pharmaceutical and biotech companies. This chart shows general expectations for the healthcare sector. The IPA's position relative to the average reflects market sentiment regarding their technology platform and demand for antibody development outsourcing.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772684597602 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
ImmunoPrecise Antibodies is a biotech company that provides therapeutic antibody discovery and development services to other pharmaceutical companies. It uses various platforms, including mice and llamas, to create antibodies. This chart of overall market expectations provides a backdrop for evaluating companies that form part of the biotech industry's infrastructure.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772684597617 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) that specializes in the discovery and development of therapeutic antibodies for other pharmaceutical companies. Its revenue, shown in the chart, is generated by fees for these research services.
Profit of companies in the market segment - Dna
ImmunoPrecise Antibodies is a company that provides therapeutic antibody development services to pharmaceutical and biotech companies. It operates in the early stages of drug development. The data in the graph reflects the overall profitability of its segment, demonstrating how actively pharmaceutical companies are investing in outsourcing research and the development of new biologics.
Overall market profit
ImmunoPrecise Antibodies is a contract research organization specializing in the discovery and development of therapeutic antibodies for other companies. Demand for its services depends on the level of R&D investment in the pharmaceutical industry. Growing overall market revenue, as shown in this graph, encourages pharmaceutical companies to spend more on research, expanding their IPA order book.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization providing therapeutic antibody discovery and development services to pharmaceutical companies. This chart shows analysts' expectations for future profits, which are influenced by the volume of R&D outsourcing in the biotech industry.
%20profit%20of%20the%20company%20ImmunoPrecise%20Antibodies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ImmunoPrecise-Antibodies&v=1772684597653 "Graph of future (projected) profit of the company ImmunoPrecise Antibodies")
Future (predicted) profit of companies in the market segment - Dna
ImmunoPrecise Antibodies is a contract research organization that helps other companies discover and develop therapeutic antibodies. The company's services are in demand at all stages of drug development. This graph shows forecasts for the entire biotech sector, helping to assess ImmunoPrecise's contribution to the creation of innovative medicine of the future.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772684597655 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
ImmunoPrecise Antibodies is a contract research organization specializing in antibody development. Demand for its services depends on the R&D budgets of pharmaceutical and biotech companies. This schedule, reflecting the state of the economy, affects the availability of funding for its clients.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772684597666 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in antibody discovery and development for pharmaceutical companies. This chart shows how the market values its scientific platform and services. The dynamics reflect the overall R&D spending in the pharmaceutical industry and the demand for outsourcing complex research tasks.
P/S market segment - Dna
ImmunoPrecise Antibodies is a contract research organization (CRO) that provides therapeutic antibody discovery and development services to pharmaceutical companies. Revenue is the fee for these services. This biotech chart helps assess how investors view ImmunoPrecise's technology platform and its role in drug discovery.
P/S of the market as a whole
ImmunoPrecise Antibodies is a biotech company that provides antibody discovery and development services to pharmaceutical companies. This market revenue valuation chart helps understand how investors value this service model in the rapidly growing field of therapeutic antibodies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization that provides therapeutic antibody discovery and development services to pharmaceutical and biotech companies. This chart shows how investors estimate future revenue from its research contracts. It reflects activity in the pharmaceutical R&D sector.
%20P%2FS%20ImmunoPrecise%20Antibodies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ImmunoPrecise-Antibodies&v=1772684597688 "The graph of the company's future (projected) P/S ImmunoPrecise Antibodies")
Future (projected) P/S of the market segment - Dna
ImmunoPrecise Antibodies is a contract research organization that provides therapeutic antibody discovery and development services to pharmaceutical and biotech companies. The company's valuation reflects the growth of R&D outsourcing and demand for its advanced platforms for the development of complex biologics.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772684597709 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in the discovery and development of therapeutic antibodies. Its business serves as a barometer of R&D activity in the pharmaceutical industry. The revenue growth expectations seen here depend on the drugs the IPA is currently developing.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772684597715 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) that provides therapeutic antibody discovery and development services. This chart shows revenue from contracts with pharmaceutical and biotech companies that outsource early-stage drug development.
Sales of companies in the market segment - Dna
ImmunoPrecise Antibodies (IPA) is a biotechnology company that provides therapeutic antibody discovery and development services to other pharmaceutical companies. This metric reflects revenue in the DNA research sector. IPA is a key partner in the R&D process, helping lay the foundation for new antibody-based drugs.
Overall market sales
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in the development of therapeutic antibodies for other companies. Its business depends on activity in the R&D sector. This general economic activity influences the funding of biotech and pharmaceutical companies that are ImmunoPrecise's clients, commissioning them to develop antibodies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) providing therapeutic antibody development services to pharmaceutical and biotech companies. Its revenue is derived from outsourcing R&D to the pharmaceutical industry. This chart shows analyst revenue expectations, which serve as a barometer of investment activity in drug development.
%20sales%20of%20the%20company%20ImmunoPrecise%20Antibodies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ImmunoPrecise-Antibodies&v=1772684597743 "Schedule of future (projected) sales of the company ImmunoPrecise Antibodies")
Future (projected) sales of companies in the market segment - Dna
ImmunoPrecise Antibodies is a company that provides therapeutic antibody development and discovery services to other pharmaceutical companies. The forecast in this chart likely segments future revenue by service type. This shows how analysts estimate the demand for outsourcing in the antibody development field.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772684597750 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
ImmunoPrecise Antibodies is a contract research organization that helps other companies discover and develop therapeutic antibodies. Its business serves the entire pharmaceutical industry. This chart shows the overall investment climate, and ImmunoPrecise's order book reflects the actual level of research activity in one of the hottest areas of biotechnology.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772684597754 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in the discovery and development of therapeutic antibodies for other pharmaceutical companies. Profitability depends on the number and complexity of projects. The chart shows how the company generates revenue within the biopharmaceutical ecosystem by providing its scientific expertise.
Market segment marginality - Dna
ImmunoPrecise Antibodies provides therapeutic antibody development and discovery services to pharmaceutical and biotech companies. This chart shows the profitability of its service business. Success depends on the quality of its scientific platform and its ability to help clients create effective biologics.
Market marginality as a whole
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in the development of antibodies for therapeutic purposes. Its clients are pharmaceutical and biotech companies. This overall profitability chart reflects the state of R&D in this industry. Increasing margins for its clients leads to increased research budgets and orders for ImmunoPrecise.
Employees in the company, segment and market as a whole
Number of employees in the company ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a biotechnology services company that assists other pharmaceutical and biotech companies in the discovery and development of therapeutic antibodies. This graphic shows the team of scientists who provide their expertise, accelerating the development of new drugs for their clients.
Share of the company's employees ImmunoPrecise Antibodies within the market segment - Dna
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in the discovery and development of therapeutic antibodies for other companies. Its core business is providing scientific services. This chart directly reflects its scientific capabilities, measuring the size of its team of scientists who help pharmaceutical companies develop new drugs.
Number of employees in the market segment - Dna
ImmunoPrecise Antibodies is a contract research organization (CRO) specializing in the development of therapeutic antibodies. This chart, reflecting employment in the DNA and antibody research sector, directly drives their business. As more pharmaceutical companies invest in R&D, the demand for ImmunoPrecise's antibody discovery and characterization services increases.
Number of employees in the market as a whole
ImmunoPrecise Antibodies is a contract research organization specializing in the discovery and development of therapeutic antibodies. Its clients include pharmaceutical and biotech companies. The growth in overall employment, reflected in this chart, indicates a healthy economy that is stimulating investment in R&D, directly increasing demand for ImmunoPrecise's outsourcing services.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies (IPA) is a contract research organization (CRO) specializing in the discovery and development of therapeutic antibodies. It is a science-intensive B2B service. This metric reflects the market's value of their technology platforms (IP) and scientific expertise per staff of scientists.
%20of%20the%20company%20ImmunoPrecise%20Antibodies%20(IPA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ImmunoPrecise-Antibodies-IPA&v=1772684597831 "Chart of market capitalization per employee (in thousands of dollars) of the company ImmunoPrecise Antibodies (IPA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
ImmunoPrecise Antibodies provides therapeutic antibody development services to pharmaceutical companies. In the CRO (contract research organization) sector, value is created through scientific expertise. This metric reflects how the market evaluates its technology platform and the quality of its services.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772684597836 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
ImmunoPrecise Antibodies is a biotech service company (CRO) that helps other companies develop therapeutic antibodies. Its business is scientific services. In this chart, ImmunoPrecise demonstrates how, in the biotech service industry, its cost per employee reflects the value of its technology platform and expertise, which are leveraged by many clients.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772684597841 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies is a contract research organization (CRO) that helps other companies discover and develop new antibodies. It's a science-intensive B2B service. This chart shows how effectively their scientists manage client projects, turning R&D services into profit.
%20Chart%20ImmunoPrecise%20Antibodies%20(IPA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ImmunoPrecise-Antibodies-IPA&v=1772684597847 "Company Profit Per Employee (in thousands of dollars) Chart ImmunoPrecise Antibodies (IPA)")
Profit per employee (in thousands of dollars) in the market segment - Dna
ImmunoPrecise Antibodies provides therapeutic antibody development and discovery services to pharmaceutical companies. In the biotech service industry, the efficiency of scientists directly impacts profitability. This metric demonstrates how effectively the company utilizes its scientific expertise to serve its clients, generating revenue per employee.
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772684597851 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
ImmunoPrecise Antibodies is a company providing therapeutic antibody discovery and development services to pharmaceutical companies. It is a CRO (Creative Research and Development Outsourcing) company. This chart, showing the average market revenue per employee, provides important context. It demonstrates how effective the biotech services sector, where IPAs operate, is in monetizing the labor of highly qualified scientists.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772684597855 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies is a contract research organization (CRO) that specializes in the discovery and development of therapeutic antibodies for other companies. Revenue per employee reflects the value of its scientific services. The graph shows how its team of scientists helps pharmaceutical companies develop new drugs and receive fees for their research.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ImmunoPrecise-Antibodies-IPA&v=1772684597860 "Sales chart per company employee ImmunoPrecise Antibodies (IPA)")
Sales per employee in the market segment - Dna
ImmunoPrecise Antibodies (IPA) is a contract research organization (CRO) specializing in the discovery and development of therapeutic antibodies for other pharmaceutical companies. This chart shows the average revenue per employee in this segment. It helps assess how effectively IPA utilizes its scientific staff to fulfill its contracts.
Sales per employee for the market as a whole
ImmunoPrecise Antibodies (IPA) is a contract research organization (CRO) that helps other companies (from biotech to pharma giants) discover and develop new therapeutic antibodies. It's a knowledge-intensive service business. This metric reflects the revenue generated from R&D services by each of its scientists.
Short shares by company, segment and market as a whole
Shares shorted by company ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies (IPA) is a biotech company providing antibody discovery and development services to other pharmaceutical companies. This chart shows short interest. The rise in bearish bets may reflect concerns about revenue volatility (service model), high cash burn on in-house development, and fierce competition in the CRO market. (347)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ImmunoPrecise-Antibodies-IPA&v=1772684597876 "Short Shares Chart for the Company ImmunoPrecise Antibodies (IPA)")
Shares shorted by market segment - Dna
ImmunoPrecise Antibodies (IPA) is a company that provides therapeutic antibody discovery and development services to other pharmaceutical companies. The chart below shows the overall short position in the biotech services (CRO) sector. It shows whether investors expect a reduction in R&D budgets in the pharmaceutical industry.
Shares shorted by the overall market
ImmunoPrecise Antibodies is a B2B company providing R&D services (antibody discovery) to other pharmaceutical companies. This chart measures overall fear. When investors are afraid, IPA clients (especially small biotechs) are the first to cut their outsourced R&D budgets to preserve their cash. This directly impacts ImmunoPrecise's order book.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies is a CRO (contract research organization) specializing in the discovery and development of antibodies for other pharmaceutical companies. It's a "shovel supplier" for biotech. This indicator "heats up" when the biotech sector is booming and R&D budgets are growing.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ImmunoPrecise-Antibodies-IPA&v=1772684597886 "RSI 14 indicator chart for the company's stock ImmunoPrecise Antibodies (IPA)")
RSI 14 Market Segment - Dna
ImmunoPrecise Antibodies (IPA) is not a pharmaceutical company, but a contract research organization (CRO). It provides antibody discovery and development services to other biotech and pharmaceutical companies. This chart measures the collective momentum of the biotech equipment and services (life science tools) sector. It shows whether the entire biotech sector is overheated or whether IPA has its own drivers.
RSI 14 for the overall market
ImmunoPrecise Antibodies (IPA) is a biotech platform. This chart is an indicator of R&D health. In the euphoria of the moment, biotechs (IPA clients) are generously funded and launch hundreds of clinical trials using the platform. In the panic, R&D funding freezes, the number of trials drops, and demand for IPA's services declines.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IPA (ImmunoPrecise Antibodies)
ImmunoPrecise Antibodies (IPA) is a CRO that provides therapeutic antibody discovery and development services to other pharmaceutical companies. This chart shows the speculative average 12-month price target from analysts, based on their forecasts for biotech R&D budgets and contract growth.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IPA-ImmunoPrecise-Antibodies&v=1772684597898 "A chart showing analyst consensus forecasts for the expected stock price. IPA (ImmunoPrecise Antibodies)")
The difference between the consensus estimate and the actual stock price IPA (ImmunoPrecise Antibodies)
ImmunoPrecise (IPA) is an antibody hunter. The company (a CRO) uses its platforms (including AI) to help Big Pharma discover and develop new drugs. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in the growth of R&D outsourcing.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IPA-ImmunoPrecise-Antibodies&v=1772684597905 "A chart showing the difference between the consensus forecast and the actual stock price. IPA (ImmunoPrecise Antibodies)")
Analyst consensus forecast for stock prices by market segment - Dna
ImmunoPrecise (IPA) is the "pick and shovel" of the biotech boom. It's a contract research organization (CRO) that uses its platforms to discover and develop antibodies *for* other pharma companies. This chart reflects the collective opinion of the *entire* R&D/DNA sector. It shows whether experts expect R&D budgets in pharma to increase or decrease.
Analysts' consensus forecast for the overall market share price
ImmunoPrecise Antibodies (IPA) is the "behind the scenes" company in biotech. They provide antibody discovery and development services (CRO) to other pharmaceutical companies. This chart shows overall market sentiment. For IPA, whose business depends on R&D budgets, the overall optimism (the rising chart) is important, as it reflects risk appetite and biotech funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ImmunoPrecise Antibodies
ImmunoPrecise is an R&D outsourcer for biotech. Their specialty isn't their own drugs; their specialty is a service platform (from animal models to AI) that other pharma companies hire to discover and develop new antibodies. This chart is a summary indicator of their service model. It reflects their (lumpy) contract portfolio and their (high) dependence on the health (funding) of the entire biotech sector.
AKIMA Market Segment Index - Dna
ImmunoPrecise Antibodies (IPA) is a biotech weapons manufacturer. They don't treat diseases themselves, but rather provide antibody discovery and development services (CRO) to other pharmaceutical companies. This is DNA and R&D services. This chart compares their composite index to the sector, showing how their biotech services are outperforming the market.
The AKIM Index for the overall market
ImmunoPrecise Antibodies (IPA) is a CRO providing AI-powered antibody discovery and development services. This chart, which reflects the market average, provides context. It helps assess how this scientific partner for biopharma stacks up against overall macroeconomic trends and R&D budgets.
